Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion type Assertion NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_head.
- NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion description "[Aberrant methylation of TFPI2 was detected in almost all CRC adenomas (97%, n = 56) and stages I to IV CRCs (99%, n = 115).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_provenance.
- NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion evidence source_evidence_literature NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_provenance.
- NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion SIO_000772 19435926 NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_provenance.
- NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion wasDerivedFrom befree-2016 NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_provenance.
- NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_assertion wasGeneratedBy ECO_0000203 NP738332.RAw1clxsfyhJSsKqQiV1Y1IuMYE1IdK9ghlkUk0PBTGnw130_provenance.